XMLH.DE vs. WRNA.DE
XMLH.DE (L&G Healthcare Technology & Innovation UCITS ETF USD Acc) and WRNA.DE (WisdomTree BioRevolution UCITS ETF USD Acc) are both Health & Biotech Equities funds - XMLH.DE tracks the ROBO Global Healthcare Technology and Innovation Index while WRNA.DE tracks the WisdomTree BioRevolution ESG Screened. Both are passively managed. Over the past 3 years, XMLH.DE returned 7.32%/yr vs 5.57%/yr for WRNA.DE. Their correlation of 0.80 suggests significant overlap in exposure. XMLH.DE charges 0.49%/yr vs 0.45%/yr for WRNA.DE.
Performance
XMLH.DE vs. WRNA.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XMLH.DE achieves a 8.53% return, which is significantly lower than WRNA.DE's 22.51% return.
XMLH.DE
- 1D
- -0.63%
- 1M
- 9.04%
- 6M
- 3.67%
- YTD
- 8.53%
- 1Y
- 37.82%
- 3Y*
- 7.32%
- 5Y*
- -2.65%
- 10Y*
- —
WRNA.DE
- 1D
- 0.00%
- 1M
- 12.57%
- 6M
- 14.02%
- YTD
- 22.51%
- 1Y
- 52.40%
- 3Y*
- 5.57%
- 5Y*
- —
- 10Y*
- —
XMLH.DE vs. WRNA.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
XMLH.DE L&G Healthcare Technology & Innovation UCITS ETF USD Acc | 8.53% | 11.69% | 8.01% | -4.50% | -29.19% | -0.38% |
WRNA.DE WisdomTree BioRevolution UCITS ETF USD Acc | 22.51% | 9.13% | -10.92% | -3.37% | -22.01% | -1.48% |
Correlation
The correlation between XMLH.DE and WRNA.DE is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.65 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.75 |
Correlation (All Time) Calculated using the full available price history since Dec 9, 2021 | 0.80 |
The correlation between XMLH.DE and WRNA.DE shifts across timeframes, from 0.65 (1 year) to 0.80 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XMLH.DE vs. WRNA.DE — Risk / Return Rank
XMLH.DE
WRNA.DE
XMLH.DE vs. WRNA.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) and WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XMLH.DE | WRNA.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.05 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.32 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 2.64 | 3.92 | -1.28 |
| Martin ratioReturn relative to average drawdown | 5.92 | 10.40 | -4.47 |
Loading charts...
Drawdowns
XMLH.DE vs. WRNA.DE - Drawdown Comparison
The maximum XMLH.DE drawdown since its inception was -51.48%, roughly equal to the maximum WRNA.DE drawdown of -52.35%. Use the drawdown chart below to compare losses from any high point for XMLH.DE and WRNA.DE.
Loading charts...
Drawdown Indicators
| XMLH.DE | WRNA.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.48% | -52.35% | +0.87% |
Max Drawdown (1Y)Largest decline over 1 year | -15.46% | -13.42% | -2.04% |
Max Drawdown (3Y)Largest decline over 3 years | -28.40% | -39.34% | +10.94% |
Max Drawdown (5Y)Largest decline over 5 years | -50.58% | — | — |
Current DrawdownCurrent decline from peak | -21.16% | -12.10% | -9.06% |
Average DrawdownAverage peak-to-trough decline | -25.17% | -26.94% | +1.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.91% | 5.06% | +1.85% |
Volatility
XMLH.DE vs. WRNA.DE - Volatility Comparison
The current volatility for L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) is 6.98%, while WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) has a volatility of 7.49%. This indicates that XMLH.DE experiences smaller price fluctuations and is considered to be less risky than WRNA.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XMLH.DE | WRNA.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.98% | 7.49% | -0.51% |
Volatility (6M)Calculated over the trailing 6-month period | 16.00% | 16.93% | -0.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.03% | 27.57% | -6.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.53% | 24.17% | -1.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.79% | 24.17% | -0.38% |
XMLH.DE vs. WRNA.DE - Expense Ratio Comparison
XMLH.DE has a 0.49% expense ratio, which is higher than WRNA.DE's 0.45% expense ratio.
Dividends
XMLH.DE vs. WRNA.DE - Dividend Comparison
Neither XMLH.DE nor WRNA.DE has paid dividends to shareholders.
Frequently Asked Questions
XMLH.DE and WRNA.DE have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WRNA.DE is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WRNA.DE is cheaper with a 0.45% expense ratio, compared with 0.49% for XMLH.DE.
XMLH.DE tracks ROBO Global Healthcare Technology and Innovation Index, while WRNA.DE tracks WisdomTree BioRevolution ESG Screened. They also come from different issuers: L&G and WisdomTree. Their fees differ too: 0.49% for XMLH.DE and 0.45% for WRNA.DE.
Find the right allocation for XMLH.DE and WRNA.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer